1. Mystakidou K, Parpa E, Tsilika E, Pathiaki M, Galanos A, Vlahos L. Comparison of pain quality descriptors in cancer patients with nociceptive and neuropathic pain. In Vivo. 2007;21:93–7.
2. Portenoy RK, Miransky J, Thaler HT, et al. Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics, and effect. Cancer. 1992;70:1616–24.
3. WHO guidelines approved by the guidelines review committee. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. Geneva: World Health Organization. 2018. https://www.who.int/publications/i/item/9789241550390. Accessed 1 May 2022.
4. Arcidiacono PG, Calori G, Carrara S, McNicol ED, Testoni PA. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev. 2011;2011:CD007519.
5. Yoon DM, Yoon KB, Baek IC, Ko SH, Kim SH. Predictors of analgesic efficacy of neurolytic celiac plexus block in patients with unresectable pancreatic cancer: the importance of timing. Support Care Cancer. 2018;26:2023–30.